|
Volumn 18, Issue 2, 2000, Pages 93-96
|
Split-course radiotherapy with or without concurrent or sequential chemotherapy in non-small cell lung cancer
a a a a a |
Author keywords
Cisplatin; Concomitant; Non small cell lung cancer; Radiotherapy; Sequential
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
ETOPOSIDE;
IFOSFAMIDE;
ADULT;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ESOPHAGITIS;
FEMALE;
HUMAN;
LEUKOPENIA;
LUNG NON SMALL CELL CANCER;
MALE;
MULTIMODALITY CANCER THERAPY;
NAUSEA;
RADIATION PNEUMONIA;
TREATMENT OUTCOME;
VOMITING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
COMBINED MODALITY THERAPY;
DRUG ADMINISTRATION SCHEDULE;
ETOPOSIDE;
FEMALE;
HUMANS;
IFOSFAMIDE;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
RADIOTHERAPY;
RADIOTHERAPY DOSAGE;
SURVIVAL RATE;
|
EID: 0034116743
PISSN: 02882043
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (21)
|
References (21)
|